Related Experiment Video
Updated: Jun 10, 2026
07:12
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
Movement disorders in complex regional pain syndrome
1Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. J.J.van_Hilten@lumc.nl
Pain Medicine (Malden, Mass.)
|August 14, 2010
Summary
Complex regional pain syndrome (CRPS) can cause difficult movement disorders due to spinal cord changes. Enhancing the central inhibitory state may help manage these CRPS-related motor symptoms.
Area of Science:
- Neurology
- Pain Medicine
- Neuroscience
Background:
- Complex regional pain syndrome (CRPS) affects approximately 25% of patients with movement disorders.
- These motor dysfunctions, including loss of voluntary control, bradykinesia, dystonia, myoclonus, and tremor, significantly increase the disease burden.
- Current management strategies for CRPS-related movement disorders are limited.
Purpose of the Study:
- To explore the underlying mechanisms of movement disorders in CRPS.
- To identify potential therapeutic targets for CRPS-associated motor symptoms.
Main Methods:
- Review of recent findings on spinal plasticity and central sensitization in CRPS.
- Analysis of the link between altered sensory processing, disinhibition, and motor dysfunction.
- Evaluation of fundamental and clinical research suggesting therapeutic approaches.
Main Results:
- Tissue or nerve injury in CRPS can induce spinal plasticity (central sensitization).
- This central sensitization alters sensory transmission and sensorimotor processing, leading to disinhibition.
- These neuroplastic changes are associated with the development of movement disorders in CRPS patients.
Conclusions:
- Movement disorders in CRPS are linked to central sensitization and disinhibition in the spinal cord.
- While randomized controlled studies are lacking, enhancing the central inhibitory state shows promise.
- Targeting spinal plasticity and central inhibition may offer new therapeutic avenues for CRPS movement disorders.
Related Concept Videos
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...